Nuwellis Shareholders Elect Directors, Ratify Auditor at Meeting

An update from Nuwellis ( (NUWE) ) is now available.

At its annual meeting of stockholders held on April 28, 2026, Nuwellis shareholders elected two Class I directors, Marty J. Emerson and David A. McDonald, to three-year terms ending at the 2029 annual meeting, with both candidates receiving the highest number of votes cast among those standing for election. The meeting saw 1,078,020 shares represented, or about 43.81% of shares outstanding as of the record date, and stockholders also ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, reinforcing continuity in the company’s financial oversight and corporate governance practices.

The most recent analyst rating on (NUWE) stock is a Hold with a $1.31 price target. To see the full list of analyst forecasts on Nuwellis stock, see the NUWE Stock Forecast page.

Spark’s Take on NUWE Stock

According to Spark, TipRanks’ AI Analyst, NUWE is a Neutral.

The score is driven primarily by weak financial fundamentals—ongoing large losses and negative free cash flow with reliance on external capital—despite healthy gross margins. Technicals remain unfavorable with the stock below key longer-term moving averages and negative MACD. Guidance and recent actions (margin/expense focus, acquisition, legal settlement) are constructive but are outweighed by liquidity, execution, and governance risks.

To see Spark’s full report on NUWE stock, click here.

More about Nuwellis

Nuwellis operates in the healthcare sector, with a focus on providing medical technologies and services that support patient treatment and clinical outcomes. The company’s governance structure includes a classified board of directors and reliance on established independent auditors to oversee financial reporting, reflecting a conventional public-company framework aimed at regulatory compliance and investor confidence.

Average Trading Volume: 95,734

Technical Sentiment Signal: Sell

Current Market Cap: $2.85M

Find detailed analytics on NUWE stock on TipRanks’ Stock Analysis page.